Odyssey Health, Inc. (ODYY)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 07-31. Amounts in USD.

Revenue Quarterly

0 50K 100K 150K Q1 '15: 138.3K Q2 '15: 100.9K Q3 '15: 18K Q4 '15: 0 Q1 '16: 0 Q2 '16: 0 Q3 '16: 22.5K Q4 '16: 15K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q3 '15 Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Gross Profit Quarterly

0 5K 10K 15K Q1 '15: 14.2K Q2 '15: 12.3K Q3 '15: 2.2K Q4 '15: 0 Q1 '16: 0 Q2 '16: 0 Q3 '16: 13.5K Q4 '16: 3.7K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q3 '15 Q2 '16 Q1 '17 Q4 '17 Q3 '18 Q2 '19 Q1 '20 Q4 '20

Operating Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q4 '16: -31K Q1 '17: -15.9K Q2 '17: -26K Q3 '17: -72.4K Q4 '17: -53.2K Q1 '18: -49.5K Q2 '18: -231.8K Q3 '18: -57.4K Q4 '18: -81.8K Q1 '19: -52.4K Q2 '19: -89.8K Q3 '19: -45.2K Q4 '19: -23.4M Q1 '20: -1.3M Q2 '20: -499.8K Q3 '20: -867.7K Q4 '20: -1.2M Q1 '21: -525.3K Q2 '21: -633.8K Q3 '21: -12.1M Q4 '21: -2.6M Q1 '22: -1.4M Q2 '22: -2M Q3 '22: -2.9M Q4 '22: -1.8M Q1 '23: -2.1M Q2 '23: -1.5M Q3 '23: -1.1M Q4 '23: -655.1K Q1 '24: -347.2K Q2 '24: -1.2M Q3 '24: -372.4K Q4 '24: -262.6K Q1 '25: -579.4K Q2 '25: -156.6K Q3 '25: -129.1K Q4 '25: -155.7K Q1 '26: -303.2K Q2 '26: -181.9K Q3 '26: -297.6K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Net Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '16: -8.2K Q4 '16: -36.8K Q1 '17: -21.9K Q2 '17: -31.2K Q3 '17: -80K Q4 '17: -64.8K Q1 '18: -63.4K Q2 '18: -247.2K Q3 '18: -73.6K Q4 '18: -98.9K Q1 '19: -69.5K Q2 '19: -106.5K Q3 '19: -62.8K Q4 '19: -23.2M Q1 '20: -1.4M Q2 '20: -600.9K Q3 '20: -999.3K Q4 '20: -1.3M Q1 '21: -711.5K Q2 '21: -869.3K Q3 '21: -12.4M Q4 '21: -2.9M Q1 '22: -1.6M Q2 '22: -1.7M Q3 '22: -3.1M Q4 '22: -2M Q1 '23: -2.1M Q2 '23: -1.7M Q3 '23: -1.3M Q4 '23: -814K Q1 '24: -538K Q2 '24: 13.3M Q3 '24: -842.3K Q1 '25: -1M Q2 '25: -220.1K Q3 '25: -251.7K Q4 '25: -251.9K Q1 '26: -483.4K Q2 '26: -3.6M Q3 '26: 765.9K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q2 '25 Q3 '26

Cost of Revenue Quarterly

0 Q3 '17: 0 Q4 '17: 0 Q1 '18: 0 Q2 '18: 0 Q3 '18: 0 Q4 '18: 0 Q1 '19: 0 Q2 '19: 0 Q3 '19: 0 Q4 '19: 0 Q1 '20: 0 Q2 '20: 0 Q3 '20: 0 Q4 '20: 0 Q4 '17 Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q2 '20 Q4 '20

Operating Cash Flow Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q4 '16: -9.4K Q1 '17: -1.6K Q2 '17: 17.3K Q3 '17: -95.3K Q4 '17: -37.1K Q1 '18: -31.7K Q2 '18: -61.4K Q3 '18: -3K Q4 '18: -50K Q1 '19: -18.4K Q2 '19: -376 Q3 '19: -29.4K Q4 '19: -56.7K Q1 '20: -214.8K Q2 '20: -99.6K Q3 '20: -26.1K Q4 '20: -308.7K Q1 '21: -303.5K Q2 '21: -310.9K Q3 '21: -1.8M Q4 '21: -714.6K Q1 '22: -1.2M Q2 '22: -419.6K Q3 '22: -970K Q4 '22: 1.1M Q1 '23: -284.7K Q2 '23: -903.9K Q3 '23: -166.2K Q4 '23: -119.8K Q1 '24: -59.9K Q2 '24: -907.5K Q3 '24: -184.1K Q4 '24: -63.6K Q1 '25: -248.5K Q2 '25: -46.7K Q3 '25: -4K Q4 '25: -48.2K Q1 '26: -284K Q2 '26: -284.3K Q3 '26: -318.5K Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Free Cash Flow Quarterly

-1.2M -800K -400K 0 400K 800K 1.2M Q1 '22: -1.2M Q1 '23: -292.7K Q1 '22 Q1 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 70M 140M 210M Q1 '15: 114.8M Q2 '15: 114.8M Q3 '15: 114.8M Q1 '16: 114.8M Q2 '16: 114.8M Q3 '16: 114.8M Q1 '17: 114.8M Q2 '17: 114.8M Q3 '17: 114.8M Q1 '18: 14.8M Q2 '18: 116.4M Q3 '18: 119.8M Q1 '19: 61.4M Q2 '19: 64.7M Q3 '19: 68.7M Q1 '20: 87M Q2 '20: 87.1M Q3 '20: 87.2M Q3 '21: 93.4M Q1 '22: 88.1M Q2 '22: 91.6M Q3 '22: 83.9M Q1 '23: 80.9M Q2 '23: 81.8M Q3 '23: 83.2M Q1 '24: 81M Q2 '24: 114.1M Q3 '24: 103.8M Q1 '25: 104.7M Q2 '25: 104.7M Q3 '25: 104.7M Q1 '26: 106M Q2 '26: 107.9M Q3 '26: 186.7M Q1 '16 Q3 '17 Q2 '19 Q3 '21 Q2 '23 Q1 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q4 '15: 0.00 Q1 '16: 0.00 Q2 '16: 0.00 Q3 '16: 0.00 Q4 '16: 0.00 Q1 '17: 0.00 Q2 '17: 0.00 Q3 '17: 0.00 Q4 '17: 0.00 Q1 '18: 0.00 Q2 '18: 0.00 Q3 '18: 0.00 Q4 '18: 0.00 Q1 '19: 0.00 Q2 '19: 0.00 Q3 '19: 0.00 Q4 '19: -0.34 Q1 '20: -0.36 Q2 '20: -0.37 Q3 '20: -0.38 Q4 '20: -0.06 Q1 '21: -0.05 Q2 '21: -0.05 Q3 '21: -0.17 Q4 '21: -0.18 Q1 '22: -0.19 Q2 '22: -0.20 Q3 '22: -0.11 Q4 '22: -0.10 Q1 '23: -0.11 Q2 '23: -0.11 Q3 '23: -0.09 Q4 '23: -0.08 Q1 '24: -0.06 Q2 '24: 0.08 Q3 '24: 0.09 Q4 '25: -0.02 Q1 '26: -0.01 Q2 '26: -0.04 Q3 '26: -0.03 Q4 '16 Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.